Navigating the selection of high-purity bioregulatory tripeptides for preclinical pulmonary research requires stringent analytical verification and transparent supplier quality controls. PX1 Research supplies research-grade Chonluten (Glu-Asp-Gly) manufactured under strict quality management systems for in vitro and animal model evaluation.
Navigating the selection of high-purity bioregulatory tripeptides for preclinical pulmonary research requires stringent analytical verification and transparent supplier quality controls. PX1 Research supplies research-grade Chonluten (Glu-Asp-Gly) manufactured under strict quality management systems for in vitro and animal model evaluation.
Evaluating a supplier for research-grade Chonluten intended for preclinical asthma and airway inflammation models requires strict adherence to analytical standards. PX1 Research supplies high-purity synthetic Chonluten (Glu-Asp-Gly) strictly for in vitro assays and animal research. Each lot undergoes rigorous testing—including RP-HPLC purity verification, mass spectrometry identity confirmation, and LAL endotoxin testing—to ensure experimental reproducibility across pulmonary research workflows.
Researchers investigating bronchial epithelial integrity, cytokine regulation, and cellular remodeling in airway hyperresponsiveness models depend on consistent peptide synthesis. Sourcing from a domestic USA supplier like PX1 Research eliminates supply chain volatility and ensures comprehensive lot-specific documentation for every order of our Chonluten research compounds.
Chonluten is a synthetic short-chain peptide consisting of three amino acid residues: L-glutamyl-L-aspartyl-glycine (H-Glu-Asp-Gly-OH). Classified within the Khavinson peptide bioregulator family, it was developed to mimic short endogenous signaling sequences that interact directly with chromatin structure and specific histone proteins in respiratory cell lines.
With a precise molecular weight of 305.24 g/mol, the tripeptide structure exhibits high solubility in aqueous buffer systems. Its small size allows for rapid molecular diffusion in vitro, making it a valuable target of inquiry when analyzing gene expression changes in bronchial mucosal cells, lung fibroblasts, and alveolar macrophage cultures.
To explore the broader category of short-chain tissue-specific bioregulators, scientists can review our complete catalog of all research peptides currently available for academic and commercial laboratory investigation.
In preclinical pulmonary models, researchers utilize Chonluten to investigate its potential role in modulating inflammatory cascades within the respiratory epithelium. In vitro data indicate that short peptide sequences like Glu-Asp-Gly can penetrate nuclear membranes and bind directly to DNA regulatory regions, potentially altering the transcription of pro-inflammatory cytokines such as interleukin-4 (IL-4), interleukin-5 (IL-5), and tumor necrosis factor-alpha (TNF-α).
Asthma model research frequently focuses on airway hyperresponsiveness and goblet cell hyperplasia. Animal studies suggest that administration of Chonluten in rodent models of allergic airway inflammation may help stabilize bronchial epithelial barrier function, reduce neutrophil and eosinophil infiltration into bronchoalveolar lavage fluid (BALF), and downregulate expression of inducible nitric oxide synthase (iNOS).
Furthermore, preclinical literature highlights potential antioxidant effects. By enhancing the transcript levels of endogenous antioxidant enzymes—such as superoxide dismutase (SOD) and glutathione peroxidase (GPx)—Chonluten is actively evaluated for its capacity to mitigate reactive oxygen species (ROS) induced damage in challenged lung tissue cultures.
When designing comparative protocols for respiratory mucosal repair, inflammatory modulation, or tissue cytoprotection, researchers often evaluate Chonluten alongside related short-chain bioregulators and synthetic peptides. Understanding the distinct structural profiles and cellular targets of these compounds is essential for structuring robust controlled experiments.
While Chonluten (Glu-Asp-Gly) specifically targets bronchial epithelial gene expression and pulmonary inflammatory pathways, Bronchogen research protocols focus on a distinct tetrapeptide sequence (Ala-Glu-Asp-Leu) optimized for broader tracheobronchial tree remodeling. In contrast, researchers studying systemic cell survival and telomere stability often incorporate Epitalon bioregulator assays, whereas experiments targeting general mucosal cytoprotection and microvascular repair frequently utilize BPC-157 cytoprotective mechanisms. Evaluating these compounds side-by-side provides critical insight into tissue-specific transcription modulation versus broad-spectrum cellular repair pathways.
The validity of preclinical pulmonary research depends entirely on compound purity and batch consistency. Contaminants such as truncated peptide sequences, residual TFA (trifluoroacetic acid), heavy metals, or bacterial endotoxins can skew cellular assays, trigger false inflammatory responses, or cause premature cell mortality in culture.
PX1 Research enforces an uncompromising quality verification protocol for every lot of Chonluten manufactured. Laboratory procurement teams can independently review technical data to verify quality standards across key parameters:
1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Establishes chemical purity, ensuring every lot meets or exceeds a minimum 98% purity standard. 2. Electrospray Ionization Mass Spectrometry (ESI-MS): Confirms exact molecular weight and structural identity, verifying the absence of sequence deletion mutations. 3. Limulus Amebocyte Lysate (LAL) Endotoxin Assay: Quantifies endotoxin content to ensure levels remain strictly below laboratory safety thresholds (<0.01 EU/mg), preventing non-specific immune activation in delicate cell assays.
Detailed breakdowns of analytical methodologies and raw chromatograms are maintained in our online research library hub for full scientific transparency.
Chonluten is supplied as a lyophilized (freeze-dried) powder in sealed, sterile glass vials to ensure long-term chemical stability. Proper handling under aseptic conditions is required to maintain compound integrity prior to in vitro or animal administration protocols.
For solubilization, researchers typically reconstitute Chonluten using sterile Bacteriostatic Water, Sterile Water for Injection, or Phosphate-Buffered Saline (PBS, pH 7.4). Due to its hydrophilic tripeptide structure, Chonluten dissolves rapidly without requiring aggressive vortexing or sonication. Gentle swirling is recommended to bring the powder into complete solution.
For detailed technical instructions on calculating molar concentrations, handling lyophilized cakes, and avoiding peptide aggregation during prep, consult our specialized guide on peptide purity and reconstitution protocols.
Maintaining cold-chain integrity is critical to preserving peptide bond stability over time. Lyophilized Chonluten should be stored in a freezer at -20°C for short-to-medium term storage, or at -80°C for long-term preservation. Under these sub-zero conditions, the dry peptide remains stable for up to 24 months without measurable degradation.
Once reconstituted into an aqueous solution, the compound should be aliquoted into single-use cryogenic vials to avoid repeated freeze-thaw cycles, which can cleavage peptide bonds and reduce active concentration. Reconstituted liquid solutions should be stored at 2°C to 8°C and utilized within 3 to 4 weeks, or frozen at -20°C for extended use.
PX1 Research ships all orders directly from our domestic logistics facilities in California and Arizona. Fast processing and protective insulated packaging safeguard compound integrity during transit.
Whether executing exploratory in vitro screening or scaling up multi-arm animal model trials, academic research institutions, biotechnology firms, and contract research organizations (CROs) require dependable bulk procurement channels. PX1 Research provides scalable sourcing options tailored to institutional requirements.
Our supply program provides dedicated account support, custom lot reservation, bulk volume discounts, and standardized documentation packages for institutional compliance. Principal investigators and procurement managers can register for a direct wholesale lab account to access dedicated pricing structures and streamlined ordering workflows for ongoing research projects.
What is Chonluten intended for in laboratory settings?
Chonluten (Glu-Asp-Gly) is a synthetic tripeptide supplied exclusively for laboratory research use. In preclinical studies, it is investigated for its potential to modulate gene expression, reduce bronchial mucosal inflammation, and stabilize epithelial tissues in cellular and animal models of respiratory stress.
How does PX1 Research verify the purity of Chonluten?
Every lot of Chonluten undergoes third-party verification using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity analysis (>98%), Electrospray Ionization Mass Spectrometry (ESI-MS) for molecular identity confirmation, and LAL testing for endotoxin levels.
Can Chonluten be used for human medical treatments or asthma therapy?
No. Chonluten provided by PX1 Research is strictly for in vitro laboratory experimentation and animal research models. It is not approved for human consumption, clinical use, diagnosis, or therapeutic administration.
What solvent is recommended for reconstituting Chonluten?
For most laboratory protocols, Chonluten easily dissolves in sterile Phosphate-Buffered Saline (PBS, pH 7.4), sterile water, or bacteriostatic water. Researchers should select the solvent that aligns with their specific assay or culture medium requirements.
What are the recommended storage conditions for Chonluten?
Lyophilized Chonluten should be stored at -20°C or -80°C upon receipt. Reconstituted liquid solutions should be stored at 2°C to 8°C for short-term use (up to 30 days) or aliquoted and frozen at -20°C to prevent freeze-thaw degradation.
What endotoxin limits does PX1 Research guarantee for research peptides?
PX1 Research ensures that all laboratory-grade research peptides maintain strict endotoxin thresholds, typically below 0.01 EU/mg, preventing non-specific immunological artifacts in sensitive biological assays.
How does Chonluten compare to Bronchogen in research applications?
While both are bioregulatory short peptides studied in pulmonary contexts, Chonluten is a tripeptide (Glu-Asp-Gly) primary focused on bronchial epithelial response, whereas Bronchogen is a tetrapeptide (Ala-Glu-Asp-Leu) evaluated for broader pulmonary remodeling.
Where are PX1 Research compounds synthesized and shipped from?
PX1 Research compounds are manufactured in GMP-compliant facilities and shipped directly from domestic distribution centers located in California and Arizona, ensuring fast delivery and reliable supply chains.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.